Pharmaron Beijing Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 4.17%

Pharmaron Beijing Co Ltd (300759) has an Asset Resilience Ratio of 4.17% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.08 Billion

≈ $157.33 Million USD Cash + Short-term Investments

Total Assets

CN¥25.80 Billion

≈ $3.78 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2024)

This chart shows how Pharmaron Beijing Co Ltd's Asset Resilience Ratio has changed over time. Check 300759 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Pharmaron Beijing Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300759 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.08 Billion	4.17%
Total Liquid Assets	CN¥1.08 Billion	4.17%

Asset Resilience Insights

Limited Liquidity: Pharmaron Beijing Co Ltd maintains only 4.17% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Pharmaron Beijing Co Ltd Industry Peers by Asset Resilience Ratio

Compare Pharmaron Beijing Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	5.66%
Abivax SA PA:ABVX	Biotechnology	2.34%
Merus BV NASDAQ:MRUS	Biotechnology	29.69%
Suzhou Zelgen Biopharmaceuticals Co Ltd SHG:688266	Biotechnology	0.54%
Beijing Hotgen Biotech Co Ltd SHG:688068	Biotechnology	20.87%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	2.34%
Starlake Bioscience Co Inc Zhaoqing Guangdong SHG:600866	Biotechnology	0.29%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%

Annual Asset Resilience Ratio for Pharmaron Beijing Co Ltd (2018–2024)

The table below shows the annual Asset Resilience Ratio data for Pharmaron Beijing Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.66%	CN¥1.12 Billion ≈ $163.20 Million	CN¥23.93 Billion ≈ $3.50 Billion	+2.42pp
2023-12-31	2.24%	CN¥594.33 Million ≈ $86.97 Million	CN¥26.48 Billion ≈ $3.87 Billion	-1.39pp
2022-12-31	3.64%	CN¥745.36 Million ≈ $109.07 Million	CN¥20.49 Billion ≈ $3.00 Billion	-4.82pp
2021-12-31	8.45%	CN¥1.55 Billion ≈ $227.49 Million	CN¥18.39 Billion ≈ $2.69 Billion	+0.81pp
2020-12-31	7.64%	CN¥910.01 Million ≈ $133.16 Million	CN¥11.91 Billion ≈ $1.74 Billion	+5.79pp
2019-12-31	1.85%	CN¥183.45 Million ≈ $26.84 Million	CN¥9.94 Billion ≈ $1.45 Billion	+1.84pp
2018-12-31	0.01%	CN¥412.62K ≈ $60.38K	CN¥4.63 Billion ≈ $676.85 Million	--

pp = percentage points

About Pharmaron Beijing Co Ltd

SHE:300759 China Biotechnology

Market Cap

$7.67 Billion

CN¥52.39 Billion CNY

Market Cap Rank

#2678 Global

#314 in China

Share Price

CN¥35.48

Change (1 day)

-8.08%

52-Week Range

CN¥21.72 - CN¥40.30

All Time High

CN¥10080.27